Skip to content
10-Q

Quarterly Report

PROTECT PHARMACEUTICAL Corp

0001493152-19-002734

← back to feed
Filed
Mar 1, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2018 · Mar 31, 2018 1.36M sh
Shares Diluted Q1 2018 · Mar 31, 2017 1.11M sh
Shares Outstanding Q1 2018 · Mar 31, 2018 1.11M sh
Operating Cash Flow Q1 2018 · Mar 31, 2018 $100
Cash And Equivalents Q1 2018 · Mar 31, 2018 $100
Stockholders Equity Q1 2018 · Mar 31, 2018 −$147.17K
Stockholders Equity Q1 2018 · Dec 31, 2017 −$143.44K
Current Liabilities Q1 2018 · Mar 31, 2018 $46.27K
Current Liabilities Q1 2018 · Dec 31, 2017 $42.44K
Total Liabilities Q1 2018 · Mar 31, 2018 $147.27K
Total Liabilities Q1 2018 · Dec 31, 2017 $143.44K
Current Assets Q1 2018 · Mar 31, 2018 $100
Total Assets Q1 2018 · Mar 31, 2018 $100
Total Assets Q1 2018 · Dec 31, 2017 $0
Eps Diluted Q1 2018 · Mar 31, 2018 $0.00
Eps Diluted Q1 2018 · Mar 31, 2017 −$0.01
Net Income Q1 2018 · Mar 31, 2018 −$3.73K
Net Income Q1 2018 · Mar 31, 2017 −$15.4K
Sga Expense Q1 2018 · Mar 31, 2017 $200
Operating Income Q1 2018 · Mar 31, 2017 −$15.4K